|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 5/06 | (2006.01) |
| A61P 5/10 | (2006.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 15/08 | (2006.01) | ||
| C07K 14/59 | (2006.01) | ||
| A61K 38/00 | (2006.01) |
| (11) | Number of the document | 3098234 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16179121.5 |
| Date of filing the European patent application | 2009-04-16 | |
| (97) | Date of publication of the European application | 2016-11-30 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-31 |
| (46) | Date of publication of the claims translation | 2024-09-10 |
| (30) | Number | Date | Country code |
| 45424 P | 2008-04-16 | US | |
| 08251528 | 2008-04-25 | EP |
| (72) |
COTTINGHAM, Ian , CH
PLAKSIN, Daniel , CH
WHITE, Richard, Boyd , US
|
| (73) |
Ferring B.V. ,
Polaris Avenue 144, 2132 JX Hoofddorp,
NL
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Rekombinantinis FSH, apimantis alfa 2,3- ir alfa 2,6-sialilinimą |
| RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SIALYLATION |
| Payment date | Validity (years) | Amount | |
| 2025-04-02 | 17 | 347.00 EUR |
| 2026-04-16 |